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Abstract
Background: Although cardiovascular magnetic resonance (CMR) is showing increasingly diagnostic potential in
left ventricular non-compaction (LVNC), relatively little research relevant to CMR is conducted in children with LVNC.
This study was performed to characterize and compare CMR features and clinical outcomes in children with LVNC
with and without late gadolinium enhancement (LGE).
Methods: A cohort of 40 consecutive children (age, 13.7 ± 3.3 years; 29 boys and 11 girls) with isolated LVNC underwent
a baseline CMR scan with subsequent clinical follow-up. Short-axis cine images were used to calculate left ventricular (LV)
ejection fraction (EF), end-diastolic volume (EDV), end-systolic volume (ESV), myocardial mass, ratio of non-compacted-to-
compacted myocardial thickness (NC/C ratio), and number of non-compacted segments. The LGE images were analyzed
to assess visually presence and patterns of LGE. The primary end point was a composite of cardiac death and
heart transplantation.
Results: The LGE was present in 10 (25 %) children, and 46 (27 %) segments were involved, including 23
non-compacted segments and 23 normal segments. Compared with LGE- cohort, LGE+ cohort had significantly
lower LVEF (23.8 ± 10.7 % vs. 42.9 ± 16.7 %, p < 0.001) and greater LVEDV (169.2 ± 65.1 vs. 118.2 ± 48.9 mL/m2, p = 0.010),
LVESV (131.3 ± 55.5 vs. 73.3 ± 46.7 mL/m2, p = 0.002), and sphericity indices (0.75 ± 0.19 vs. 0.60 ± 0.20, p = 0.045). There
were no differences in terms of number and distribution of non-compacted segments, NC/C ratio, and myocardial mass
index between LGE+ and LGE- cohort. In the LGE+ cohort, adverse events occurred in 6 patients compared to 2 events
in the LGE- cohort. Kaplan-Meier analysis showed a significant difference in outcome between LGE+ and LGE- cohort for
cardiac death and heart transplantation (p = 0.011).
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Conclusions: The LGE was present in up to one-fourth of children with LVNC, and the LGE+ children exhibited a more
maladaptive LV remodeling and a higher incidence of cardiovascular death and heart transplantation.
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Background
Left ventricular non-compaction (LVNC) is a genetically
and clinically heterogeneous cardiomyopathy character-
ized by numerous prominent trabeculations, progressive
myocardial dysfunction, malignant ventricular arrhythmias,
and early mortality [1, 2]. Left ventricular non-compaction
can present in isolation or in combination with other con-
genital heart diseases or genetic neuromuscular conditions
[3–5]. Previous work has shown that LVNC accounts for
about 9 % of cardiomyopathy in childhood [6]. The inci-
dence of isolated LVNC diagnosed at children echocardio-
grams was estimated to be approximately 0.2 % [7].
Cardiovascular magnetic resonance (CMR) may out-
perform echocardiography in assessing the whole left
ventricular (LV) myocardium and also provide precise
identification of prominent trabeculations owing to its
higher spatial resolution and field of view [8–10]. Further-
more, CMR with late gadolinium enhancement (LGE)
is a reliable technique for detecting myocardial fibrosis
in vivo, which is related to clinical severity grading and
prognosis in adult patients with LVNC [11–15]. Although
CMR is showing increasingly diagnostic potential in LVNC,
works on the application of CMR in children with LVNC
are restricted to several case reports and small case series
[16–19]. Therefore, we have assembled a relatively large
cohort of children with LVNC, defined by eligibility for
CMR, to characterize and compare CMR features and clin-




We prospectively recruited a cohort of consecutive chil-
dren with isolated LVNC who were referred to the Fuwai
Hospital for CMR between June 2006 and December 2013.
The diagnosis of LVNC was made on the basis of previ-
ously defined CMR and clinical criteria: [9] (a) appearance
of 2 distinct myocardial layers; (b) prominent myocardial
trabeculations and deep intertrabecular recesses com-
municating with the LV cavity; (c) end-diastolic ratio of
non-compacted-to-compacted (NC:C) myocardium >2.3:1,
and (d) absence of other known co-existing cardiac ab-
normalities. The study complied with the Declaration of
Helsinki and was approved by the Fuwai Hospital ethics
committee, and informed consent was obtained from the
parents of each child with LVNC.
CMR image acquisition and analysis
All CMR exams were performed using a 1.5-T scanner
(Siemens Avanto). Retrospective electrocardiographic gated
cine images were performed using true fast imaging with
steady-state free precession sequence (image parameters:
repetition time/echo time [TR/TE] = 40.0/1.1 ms; matrix =
256 × 192 mm; flip angle = 62°) in three long-axis (horizontal
and vertical long-axis and LV outflow tract) and con-
tinuous short-axis views covering the entire LV from base to
apex. Fifteen ± 5 min after the injection of 0.2 mmol/kg of
gadolinium-DTPA (Magnevist; Schering, Berlin, Germany),
the LGE images were obtained using an inversion recovery
sequence (image parameters: TR/TE = 8.7/3.4 ms, matrix =
256 × 256 mm, flip angle = 15°) in three long-axis and stand-
ard short-axis views covering the whole LV.
All images were analyzed using a workstation with com-
mercially available software (Siemens Argus). For children
with multiple CMR studies, the initial baseline study was
used for the primary analysis. Results for LV ejection frac-
tion, ventricular volumes, and myocardial mass were de-
rived from short-axis slices. As previously demonstrated,
the papillary muscles were excluded from compacted
myocardium because it is difficult to differentiate papil-
lary muscles from dense trabeculations [20]. Left ven-
tricular volumes and compacted mass were indexed to
body surface area. The LV sphericity index was calcu-
lated as: end-diastolic volume (EDV)/([end-diastolic long-
axis diameter3 × π]/6) [21]. The presence or absence of
non-compaction and LGE was qualitatively assessed using
the AHA 17 segment model [22]. For each segment with
non-compaction, the end-diastole NC/C ratio was quanti-
tatively calculated in the short-axis views, and the max-
imum ratio was then used for analysis. As previously
demonstrated, the assessment of NC/C ratio of the apex
(segment 17) was excluded [9]. LGE was deemed present
only if myocardial enhancement was confirmed on both
short-axis and matching long-axis areas using a signal in-
tensity threshold of ≥ 6 standard deviations (SD) above a
remote reference region (Fig. 1). The myocardial layer dis-
tributions of LGE were assessed using the following scale:
1 = subepicardial, 2 = mid-wall, 3 = subendocardial, and
4 = transmural (≥75 % LV wall thickness). The LGE score
was finally summed. The evaluations of non-compaction
and LGE were performed by 2 independent expert readers
(ML and HC) who were blinded to the clinical data.
Discordant findings were resolved by consensus.
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Follow-up
All children were followed up via clinic visits or telephone
interview after initial CMR examination. The endpoint of
the study was cardiovascular death and heart transplant-
ation. The duration of follow-up was determined from the
first CMR evaluation date to the occurrence of an end-
point. Complete follow-up was available for all children.
Statistical analysis
Normality was tested using the Kolmogorov-Smirnov test.
Continuous variables were expressed as mean ± SD and
assessed using unpaired t tests or Wilcoxon’s rank-sum
tests. Categorical variables were expressed as frequencies
(percentages) and assessed using the χ2 or Fisher exact
tests. Correlation analyses were performed using the Spear-
man’s rank correlation test. Survival curve was generated
by the Kaplan-Meier method and compared by the log
rank test. The statistical analysis was performed using SPSS
for Windows 16.0 (Chicago, IL, USA). A two tailed p value
of < 0.05 was considered statistically significant.
Results
Baseline characteristics
A cohort of 40 children was diagnosed with isolated LVNC.
An additional 8 children with prominent trabeculations
who met CMR diagnostic criteria were associated with ei-
ther congenital heart diseases and thus excluded from the
study, such as atrial septal defect (n = 4), Ebstein’s anomaly
(n = 1), aorto-left ventricular tunnel (n = 1), membranous
subaortic stenosis (n = 1), bicuspid aortic valve (n = 1).
Twenty-nine children (72 %) were male and 11 (28 %)
were female. The mean age at the time of initial CMR
scan was 13.7 ± 3.3 years (range, 1.5-17 years). Three
children (8 %) had a family history of LVNC. Twenty-one
children (53 %) presented primarily with signs and symp-
toms of congestive heart failure. Seven children (18 %)
presented with documented ventricular arrhythmias
and 1 patient (3 %) presented with aborted sudden death.
Five children (13 %) were referred for evaluation of unex-
plained syncope. Two children (5 %) presented with a pri-
mary complaint of chest pain. No children had signs of
systemic emboli. Clinical and demographic characteristics
of the study population are summarized in Table 1.
CMR findings
The detailed CMR characteristics of children with LVNC
are listed in Table 2. The mean LV ejection fraction (EF)
and EDV index were 38.1 ± 17.4 % and 131.0 ± 55.8 mL/m2,
respectively. No thrombus was detected in LV cavity on
CMR. Non-compaction was present in 372 LV segments.
The mean number of non-compacted segments per pa-
tient was 9.3 ± 2.5. The mean NC/C ratio was 3.64 ± 0.94.
A total of 10 (25 %) children with LVNC showed LV
LGE. The LGE was observed in 46 segments, including
23 non-compacted segments and 23 normal segments.
Of these, LGE was subendocardial in 11 segments, mid-wall
in 18, subepicardial in 5, and transmural in 12. No as-
sociation was found between myocardial layer distribu-
tions of LGE and LVEF (r = 0.49, p = 0.148). Compared
LGE- children, LGE+ children had significantly lower
LVEF (23.8 ± 10.7 % vs. 42.9 ± 16.7 %, p < 0.001) and greater
LVEDV (169.2 ± 65.1 vs. 118.2 ± 48.9 mL/m2, p = 0.010), LV
end-systolic volume (131.3 ± 55.5 vs. 73.3 ± 46.7 mL/m2,
p = 0.002), and sphericity indices (0.75 ± 0.19 vs. 0.60 ±
0.20, p = 0.045). There were no differences in terms of
number of non-compacted segments, NC/C ratio, and
Fig. 1 Representative images of LGE in a 16-year-old boy with LVNC. The vertical (a) and horizontal (c) long-axis and short-axis (b and d)
contrast-enhanced images demonstrate transmural LGE in the septal and inferior segments
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myocardial mass index between LGE+ and LGE- cohort.
There was a similar distribution of non-compaction
between LGE+ and LGE- children, which was more fre-
quently observed on the apical segment than on the mid-
cavity and basal segments (Fig. 2).
Follow-up
The average length of follow-up was 3.0 ± 2.2 years. Dur-
ing follow-up period, 6 children (15 %) died and 2 (5 %)
underwent heart transplantation (Fig. 3), thereby resulting
in a 20 % incidence of death and transplantation in the
Table 1 Baseline characteristics
All Children Presence of LGE
Variable (n = 40) Yes (n = 10) No (n = 30) p Value
Age (years) 13.7 ± 3.3 14.0 ± 2.1 13.6 ± 3.6 0.753
Male, n (%) 29 (73) 9 (90) 20 (67) 0.233
Family history of LVNC, n (%) 3 (8) 1 (10) 2 (7) 1.000
Symptoms
Dyspnoea, n (%) 21 (53) 9 (90) 12 (40) 0.004
Chest pain, n (%) 2 (5) 0 2 (7) 1.000
Syncope/pre-syncope, n (%) 7 (18) 1 (10) 6 (20) 0.651
Thrombo-embolic events, n (%) 0 0 0
NYHA functional class 2.4 ± 1.0 3.0 ± 0.9 2.1 ± 0.9 0.016
I, n (%) 10 (25) 1 (9) 9 (30)
II, n (%) 11 (28) 1 (9) 10 (33)
III, n (%) 14 (35) 5 (55) 9 (30)
IV, n (%) 5 (12) 3 (27) 2 (7)
Abnormal ECG, n (%) 36 (90) 10 (100) 26 (87) 0.559
VT/VF, n (%) 7 (18) 3 (30) 4 (13) 0.361
Medications
β-Blockers, n (%) 29 (73) 8 (80) 21 (70) 0.694
ACEI/ARB, n (%) 29 (73) 10 (100) 19 (63) 0.020
Aldosterone antagonists, n (%) 27 (68) 10 (100) 17 (57) 0.008
Loop diuretics, n (%) 22 (55) 9 (90) 13 (43) 0.011
Amiodarone, n (%) 2 (5) 2 (20) 0 0.067
Values are mean ± SD or n (%)
Table 2 Cardiovascular magnetic resonance characteristics
All Children Presence of LGE
Variable (n = 40) Yes (n = 10) No (n = 30) p Value
Heart rate (beats/min) 86.5 ± 22.8 92.3 ± 24.8 84.6 ± 22.2 0.360
Body surface area (m2) 1.6 ± 0.3 1.5 ± 0.2 1.6 ± 0.4 0.861
LV long-axis diameter (mm) 84.1 ± 12.0 86.1 ± 9.3 83.4 ± 12.8 0.534
LV Sphericity index 0.64 ± 0.21 0.75 ± 0.19 0.60 ± 0.20 0.045
LVEF (%) 38.1 ± 17.4 23.8 ± 10.7 42.9 ± 16.7 <0.001
LVEDV index (mL/m2) 131.0 ± 55.8 169.2 ± 65.1 118.2 ± 48.9 0.010
LVESV index (mL/m2) 87.8 ± 54.6 131.3 ± 55.5 73.3 ± 46.7 0.002
Stroke volume index (mL/m2) 43.2 ± 13.4 37.9 ± 17.0 44.9 ± 11.8 0.152
Myocardial mass index (mL/m2) 56.1 ± 19.0 64.6 ± 17.2 53.3 ± 19.0 0.107
Maximum NC/C ratio 3.64 ± 0.94 3.76 ± 1.24 3.60 ± 0.84 0.645
Number of non-compacted segments 9.3 ± 2.5 9.9 ± 2.8 9.1 ± 2.4 0.384
Duration of follow-up, years 3.0 ± 2.2 2.6 ± 2.3 3.2 ± 2.3 0.494
Values are mean ± SD
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total cohort. There was no statistically significant differ-
ence in the length of follow-up between LGE+ and LGE-
children (2.6 ± 2.3 versus 3.2 ± 2.3 years; p = 0.494). In
LGE+ cohort, adverse events occurred in 6 children, in-
cluding orthotropic heart transplantation in 2 children
and death in 4 children. In LGE- cohort, adverse event
was identified in 2 children. Kaplan-Meier analysis showed
a significant difference in outcome between LGE+ and
LGE- cohorts for cardiac death and heart transplantation
(Fig. 4).
Discussions
In the relatively large cohort study of children with isolated
LVNC diagnosed by CMR, we investigated and compared
CMR features and clinical outcomes between LGE+ and
LGE- children. The overall occurrence of LGE (25 %) was
lower to that found in previous adult studies [14, 15]. The
LGE+ cohort exhibited a more maladaptive LV remodeling
and higher incidence of cardiovascular death and heart
transplantation.
CMR is showing increasing diagnostic potential in LVNC
owing to a comprehensive identification and quantification
of the extent of non-compacted myocardium [10, 20, 23].
The utility of CMR with LGE for detecting myocardial fi-
brosis is well established, which has also been confirmed in
our previous report of the adult patient with LVNC [24].
Several studies have described a high prevalence of LGE in
patients with LVNC, and LGE has been shown to be asso-
ciated with ventricular arrhythmias as well as ventricular
dysfunction [12–14]. Our previous study have shown that
LGE was present in 19 (40 %) of the 47 patients and was
more common in patients with ventricular arrhythmias by
24-h Holter electrocardiography recordings [12]. Dodd et
al. [25] showed that the amount of trabecular LGE was
correlated significantly with LVEF and an independent
predictor of LVEF. Nucifora et al. [14] reported LGE
was found in 55 % of patients and correlated with clin-
ical severity and ventricular dysfunction. In keeping with
their reports, our study showed LGE+ children had more
severe LV dysfunction and NYHA functional class.
Similar to previous studies [12, 13], the distribution of
LGE was strikingly heterogeneous and involved not only
non-compacted segments but also normal segments in
Fig. 2 Anatomical distribution of non-compaction. Comparison of
distribution of non-compaction according to region between LGE+ and
LGE- children
Fig. 3 Representative images in a 14-year-old boy with LVNC underwent heart transplantation. The horizontal (a) and vertical (b) long-axis and short-axis
(c) end-diastolic cine images showed prominent trabeculations in anterior, inferior, and lateral segments at apical level. The apical short-axis section of
explanted heart (d) revealed prominent trabeculations. Contrast-enhanced image (e) demonstrated subendocardial LGE in the basal septum. Masson’s
Trichrome staining (f) confirmed the present of replacement fibrosis in corresponding subendocardial area of basal septum (green area); magnification × 50
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the present study. The exact cause of LGE in LVNC
remains incompletely determined but is possibly asso-
ciated with diminished coronary flow reserve, impaired
microcirculatory function, coronary artery embolism, and
maladaptive LV remodeling. Junga et al. [26] demonstrated
restricted myocardial perfusion and decreased flow reserve
in areas of ventricular non-compaction in children by posi-
tron emission tomography. They concluded the myocardial
perfusion defects in non-compacted areas may be the
cause of myocardial damage. Jenni et al. [27] found a
decreased of coronary flow reserve is not confined to
non-compacted segments, but extends to most segments
with wall motion abnormalities, thus coronary microcircu-
latory dysfunction could be associated with ischemia and
fibrosis in LVNC. Ridocci-Soriano et al. [28] and our pre-
vious studies [12] have demonstrated that coronary artery
thrombo-embolism may possibly account for subendo-
cardial or transmural LGE in patients with LVNC. In
addition, the adverse cardiac remodeling caused by in-
creased wall stress can result in focal cardiomyocyte ne-
crosis due to augmentation of metabolic demands as
well as coronary microcirculatory dysfunction. In the
present study, the LV adverse remodeling was more se-
vere in LGE+ children, as evidenced by higher LV vol-
ume and sphericity indices. Our study provided further
evidence for the potential relationship between myocar-
dial fibrosis and adverse remodeling.
Previous reports on pediatric LVNC associated with con-
genital heart lesions have suggested that mortality rates
were from 15 % to 20 % during follow-up [6, 7]. Recent
study of 242 children with LVNC by Brescia et al. [29]
showed that 31 children (12.8 %) died and 13 (5.4 %)
underwent heart transplantation, resulting in an 18.2 %
incidence of death and transplantation in the median
4.0 years of follow-up. Similar to their studies, incidence
of death and transplantation was 20 % in mean 3 years
of follow-up in our children study cohort. Although the
presence of LGE has been shown to be a strong discrimin-
ator of adverse outcomes in dilated and hypertrophic car-
diomyopathies [30, 31], a very limited amount of data has
been available on the prognostic value of LGE in children
with LVNC. Our study showed a significantly higher rate
of cardiac death and heart transplantation in LGE+ chil-
dren. We propose that the presence of LGE could there-
fore potentially play an important role in stratification of
treatment in children with LVNC. However, this finding
should be interpreted with caution owing to the small
sample size and lower occurrence of end-point events in
the cohort. The pathophysiology and meaning of LGE in
children with LVNC need to be elucidated in the future
studies.
Limitations
The present study has several limitations. First, the num-
ber of the cohort was still small owing to the relatively
rare pediatric entity and a single-center nature. Second,
there were potential selection and referral biases in our
cohort, given most children clinically referred for CMR
investigation had dramatic symptoms that may not be
universally applicable to all populations. Third, LGE+
children had more adverse LV remodeling at baseline,
which leads to indefinite relationship between the pres-
ence of LGE and adverse events. In order to conclusively
ascertain incremental prognostic value of LGE in children
with LVNC, larger studies with longer follow-up are
required.
Conclusions
In children with LVNC, the LGE is present in up to one-
fourth of children with LVNC, and LGE+ children exhibited
a more maladaptive LV remodeling and higher incidence of
cardiovascular death and heart transplantation. The po-
tential clinical utility of LGE in children with LVNC needs
to be investigated by larger sample size studies with longer
follow-up.
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